Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche ...
Recursion receives industry awards for drug discovery... | CPHI Online
Recursion bags $60M for AI-enabled drug discovery push | Fierce Biotech
How Recursion is accelerating drug discovery | Recursion posted on the ...
Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows ...
Collaboration with Enamine to accelerate drug discovery. | Recursion ...
Recursion Pharmaceuticals’ Promising Drug Results: Impact on Stock
Recursion Pharmaceuticals Teams Up with MIT to Boost Drug Discovery
How Recursion uses AI for drug discovery | Recursion posted on the ...
Pioneering TechBio Solutions in Drug Discovery | Recursion
Recursion Pharmaceuticals (NASDAQ:RXRX) AI-Driven Drug Discovery Offers ...
Recursion & Google Cloud Expand Partnership for Drug Discovery
Recursion Stock - Revolutionizing Drug Discovery With AI - Nanalyze
Drug Discovery, STAT! NVIDIA, Recursion Speed Pharma R&D With AI ...
Recursion and Exscientia, two leaders in the AI drug discovery space ...
Advancing Drug Discovery Outcomes with Virtual Cells at Recursion ...
Recursion axes drug programmes to streamline pipeline
Recursion Pharmaceuticals, Inc. (RXRX) Advances AI Drug Discovery Amid ...
Recursion drug discovery tech gets new US$50M; partners NVIDIA
Recursion raises $121m for AI-led drug discovery - PMLiVE
MIT and Recursion Release Boltz-2, an AI Breakthrough in Drug Discovery ...
The Netflix of Digital Biology? Recursion Is Reimagining Drug Discovery
Recursion Pharmaceuticals (RXRX) Stock Soars as AI Drug Discovery Hype ...
Recursion Pharmaceuticals & Drug Discovery's Future
Recursion Announces Promising Clinical Data on Lead AI-Based Drug ...
Recursion Pharmaceuticals CEO explains how AI could make drug ...
Recursion Pharmaceuticals Revolutionizing Drug Discovery with AI
Recursion: A story of AI drug development | Recursion posted on the ...
Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery ...
💡 How Recursion is helping to solve a key drug discovery bottleneck ...
Recursion OS – Overview and Strategic Role in Drug Discovery
Recursion Completes Supercomputer for AI Drug Discovery
Recursion Pharmaceuticals: What To Make Of This AI-Based Drug Discovery ...
AI Empowered Drug Discovery of the Future || Recursion Pharmaceuticals ...
Recursion 101: The Industrial Revolution of Drug Discovery Is Here ...
How Recursion Pharmaceuticals is Using AI to Revolutionize Drug ...
Colorectal Cancer: Recursion Pharma's AI Drug Shows Promise in Reducing ...
How Recursion uses AI to solve hard problems in drug discovery ...
Nvidia Bets $50 Million on Recursion AI for AI-Powered Drug Discovery ...
Revolutionary Drug Design at Recursion
Should Recursion and Exscientia Focus on Drug Discovery Services or ...
Recursion acquired Exscientia for $688 million to form AI drug ...
How AI is accelerating drug discovery and development | Recursion ...
Recursion Pharmaceuticals' AI-Discovered Drug Cuts FAP Polyp Burden by ...
Recursion shares perspectives with FDA on using AI and ML in drug ...
Recursion Advances AI-Enabled Cancer Drug - YouTube
Recursion Releases MolRec, a Compound Intelligence Tool for Drug ...
Recursion (RXRX): The AI Drug Factory That Wall Street Still Doesn’t ...
Recursion Pharmaceuticals: AI-driven Cancer Drug Trials And Investor ...
Nvidia invests $50 million into Recursion for drug AI - Drug Discovery ...
Recursion Pharma's ineffectiveness in drug discovery | Maxx Chatsko ...
Recursion: Transforming Drug Discovery With Its AI-Powered Drug ...
Recursion Pharmaceuticals Jumps in Debut After $436 Million IPO ...
Recursion: Speeding up drug discovery with Hex | Hex
Recursion, Exscientia, and AI drug discovery’s moment of truth ...
How Recursion's AI and automation are changing drug discovery ...
Recursion’s BioHive-2: Amazing AI Drug Discovery with Supercomputing ...
Recursion Pharmaceuticals raises $2.15M - [Jcount.com]
AI drug developers Recursion, Exscientia to merge
Recursion Pharmaceuticals Salt Lake's Recursion Pharma Nails Down $121
Roche | Scaling up Drug Discovery
Recursion Pharmaceuticals Stock (RXRX) – Price Analysis
Recursion CEO launches pre-seed fund in response to NIH cuts ...
As Pipeline Advances, Recursion Expands AI Focus to Clinical Trials
Recursion-Exscientia merger consolidates AI in drug discovery field
Recursion Receives $50 Million Investment from NVIDIA in AI-Enabled ...
[FullVer] Recursion Pharmaceuticals Mystery: Why Did the Predicted ...
NVIDIA's $50 Million Investment in Recursion Pharmaceuticals Proves ...
JPMorgan Boosts Rating on Recursion Pharmaceuticals (RXRX) Amid AI ...
AI specialist Recursion trims pipeline in latest shakeup | BioPharma Dive
Recursion Pharmaceuticals | The Org
Recursion Announces its First Major Multidisciplinary Expansion, in ...
Recursion is this wonderful place where we don't just use AI to find ...
Recursion's AI Drug Discovery Platform Achieves Clinical & Sanofi ...
Recursion Pharmaceuticals: Leveraging AI To Discover Novel Therapeutics ...
AI specialist Recursion nabs multibillion-dollar Roche partnership ...
Recursion Pharmaceuticals: Nvidia-backed Recursion's shares fall on ...
Recursion Pharmaceuticals (RXRX): Is the TUPELO REC-4881 Trial Data a ...
Recursion Pharmaceuticals readies for a major test in AI-based drugs
Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine
Recursion Pharmaceuticals - Profile
Recursion Pharmaceuticals raises $121m to map how disease affects cells ...
The Rise of Recursion Pharmaceuticals: A Biotech Stock on the Move ...
Behind the Breakthrough: How Recursion is Building an Virtual Cell for ...
Recursion Secures $239 Million in Equity Financing to Advance ...
Recursion: Unlocking Future Of Biotech With AI-Powered Drug Discovery ...
Recursion Pharmaceuticals Boosts Visibility With J.P. Morgan Conference
An extended strategy of “Recursive Tree” for characterization of drug ...
Recursion Pharma Surges: An Unexpected 12% Jump
RXRX Insider Trading | Recursion Pharmaceuticals Buys and Sells
Recursion's CCM Drug Shows 50% Patient Response in Phase 2 Trial, Meets ...
Future Tech investment articles generated using Ai technology ...
July 21, 2025 at 18:07 PM EDT
Where Are All the AI Drugs? | WIRED
📣 Big news ahead of JPM: two of Recursion's key investigational ...
NCATS’ Small Business Funding Helps Launch New Platform for Rare ...
Recursion: developing drugs with AI | Baillie Gifford
Recursion’s Promising FAP Treatment Boosts Investor Confidence
dmac on Twitter: "This is super interesting! “Recursion Pharmaceuticals ...
Recursion's Phenom-Beta aims to upend phenomics research
Recursive Algorithms | GeeksforGeeks
